Atlas
Back to Pharma Services
Fund · Service·Pharma Services

Launch Therapeutics

Boston, United Stateslaunchtx.com1expert edge

Clinical development company founded 2022 providing late-stage drug development services, regulatory strategy, and co-development partnerships with risk-financing model.

Why interesting to a deal team

Novel late-stage pharma development model de-risking timelines; backed by Carlyle and Abingworth. Co-founder/CEO transitioned to Fortrea CEO (August 2025); demonstrates CRO talent migration.

Experts connected to this company

AT

Anshul Thakral

Chief Executive Officer

Fortrea

FounderNew York

As Fortrea's new CEO executing a high-stakes CRO turnaround, and a Carlyle-connected biotech dealmaker, he sits at the center of pharma-services consolidation and clinical outsourcing trends.

Sources

Strongest evidencePage title2 public sourcesHow the grades work